PSMC2 and neoplasm: Following the successful construction of a mouse-based model by injection of GBC-SD cells with or without PSMC2 knockdown, the results of in vivo fluorescnece imaging showed markedly weaker total fluorescence intensity, as well as smaller tumor burden, in shPSMC2 group (P < 0.001, Fig. 5A, B).